Blood Neoplasia

Published by: Elsevier Inc.  

People

  1. Derkach
    Derkach
  2. Noy
    Noy
  3. Boelens
    Boelens
  4. Boussi
    Boussi
  5. Caron
    Caron
  6. Chin
    Chin
  7. Dogan
    Dogan
  8. Falchi
    Falchi
  9. Geyer
    Geyer
  10. Giralt
    Giralt

Groups

  1. Center for Hematologic Malignancies (5)
  2. Department of Medicine (5)
  3. Hematologic Malignancies, Division of (5)
  4. Population Sciences Research Program (3)
  5. Weinberg Fellows (3)
  6. Adult Leukemia (2)
  7. Biostatistics Service (2)
  8. Epidemiology and Biostatistics (2)
  9. GME, Medicine (2)
  10. Graduate Medical Education (2)
Search Within
Formats
  1. Journal Article (4)
  2. Research Letter (2)
Groups
  1. Center for Hematologic Malignancies (5)
  2. Department of Medicine (5)
  3. Hematologic Malignancies, Division of (5)
  4. Population Sciences Research Program (3)
  5. Weinberg Fellows (3)
  6. Adult Leukemia (2)

More Groups

People
  1. Andriy Derkach (2)
  2. Ariela Noy (2)
  3. Aaron Goldberg (1)
  4. Ahmet Dogan (1)
  5. Alexander Lesokhin (1)
  6. Alison Moskowitz (1)

More People

Years
  1. 2025 (2)
  2. 2024 (4)
Publishers
  1. Elsevier Inc. (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: A real-world experience
    Journal Article

    Hultcrantz, M.; Derkach, A.; Hassoun, H.; Korde, N.; MacLachlan, K.; Mailankody, S.; Patel, D.; Shah, U. A.; Tan, C. R.; Chung, D. J.; more...
    Blood Neoplasia (2025)

    Fulltext@MSK | Save
  • Response and outcomes of patients with IDH1/2- mutated accelerated/blast-phase myeloproliferative neoplasms
    Research Letter

    Goldberg, L. A.; Yoon, J. J.; Johnston, H.; Davidson, M. B.; Siddon, A.; Shallis, R. M.; Chen, E. C.; Burkart, M.; Oh, T. S.; Iyer, S. G.; more...
    Blood Neoplasia (2025)

    Fulltext@MSK | Save
  • CD5 expression in marginal zone lymphoma does not predict inferior outcome and has similarities to indolent lymphomas
    Journal Article

    Ghione, P.; Bantilan, K. S.; Joffe, E.; Palomba, M. L.; Noy, A.; Caron, P.; Hamlin, P.; Kumar, A.; Matasar, M.; Owens, C.; more...
    Blood Neoplasia (2024)

    Fulltext@MSK | Save
  • Effect of clofarabine and fludarabine exposure on outcome after pediatric allogeneic hematopoietic cell transplantation
    Research Letter

    Dekker, L.; de Koning, C. C. H.; Nijstad, A. L.; van der Elst, K. C. M.; Admiraal, R.; Versluijs, A. B.; Boelens, J. J.; Huitema, A. D. R.; Lindemans, C. A.; Nierkens, S.
    Blood Neoplasia (2024)

    Fulltext@MSK | Save
  • Intensive chemotherapy after hypomethylating agent and venetoclax in adult acute myeloid leukemia
    Journal Article

    Chin, K. K.; Valtis, Y.; Derkach, A.; Yisraeli Salman, M.; Boussi, L.; Ciervo, J.; Geyer, M. B.; Park, J. H.; Tallman, M. S.; Glass, J. L.; more...
    Blood Neoplasia (2024)

    Fulltext@MSK | Save
  • Patients with Castleman disease report mild COVID-19 symptoms and mount a humoral response to SARS-CoV-2 vaccination
    Journal Article

    Shyamsundar, S.; Pierson, S. K.; Connolly, C. M.; Teles, M.; Segev, D. L.; Werbel, W. A.; van Rhee, F.; Casper, C.; Brandstadter, J. D.; Noy, A.; more...
    Blood Neoplasia (2024)

    Fulltext@MSK | Save

    • Blood Neoplasia – authorized name for:

    Name ISSN / ISBN Publisher
    Blood Neoplasia 2950-3280 Elsevier Inc.